MASSIDDA: "Istituzione della Commissione per i prezzi dei medicamenti" (281)

This legislative proposal seeks to create a dedicated Commission to oversee and regulate the pricing of medicinal products. The goal is to ensure that essential medicines remain affordable for patients while maintaining a sustainable healthcare budget. This measure primarily affects pharmaceutical companies and the national healthcare system. It aims to introduce more transparency and control over how drug prices are set and managed.